{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:26:53Z","timestamp":1784874413399,"version":"3.55.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41584-024-01096-7","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:02:01Z","timestamp":1711533721000},"page":"290-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Low-frequency and rare genetic variants associated with rheumatoid arthritis risk"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7489-3134","authenticated-orcid":false,"given":"Vanessa L.","family":"Kronzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-4618","authenticated-orcid":false,"given":"Jeffrey A.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1901-8265","authenticated-orcid":false,"given":"Soumya","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-178X","authenticated-orcid":false,"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"1096_CR1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628\u2013634 (2021).","journal-title":"Nature"},{"key":"1096_CR2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jclinepi.2015.09.016","volume":"70","author":"JM Gaziano","year":"2016","unstructured":"Gaziano, J. M. et al. Million veteran program: a mega-biobank to study genetic influences on health and disease. J. Clin. Epidemiol. 70, 214\u2013223 (2016).","journal-title":"J. Clin. Epidemiol."},{"key":"1096_CR3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","volume":"381","author":"JC Denny","year":"2019","unstructured":"Denny, J. C. et al. The \u201cAll of Us\u201d research program. N. Engl. J. Med. 381, 668\u2013676 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1096_CR4","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.cell.2018.09.049","volume":"175","author":"IMSG Consortium","year":"2018","unstructured":"Consortium, I. M. S. G. Low-frequency and rare-coding variation contributes to multiple sclerosis risk. Cell 175, 1679\u20131687.e1677 (2018).","journal-title":"Cell"},{"key":"1096_CR5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature21039","volume":"542","author":"E Marouli","year":"2017","unstructured":"Marouli, E. et al. Rare and low-frequency coding variants alter human adult height. Nature 542, 186\u2013190 (2017).","journal-title":"Nature"},{"key":"1096_CR6","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee, A. et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet. Med. 21, 1708\u20131718 (2019).","journal-title":"Genet. Med."},{"key":"1096_CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ahg.12212","volume":"82","author":"D Curtis","year":"2018","unstructured":"Curtis, D. Construction of an exome-wide risk score for schizophrenia based on a weighted burden test. Ann. Hum. Genet. 82, 11\u201322 (2018).","journal-title":"Ann. Hum. Genet."},{"key":"1096_CR8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamacardio.2022.1061","volume":"7","author":"KJ Biddinger","year":"2022","unstructured":"Biddinger, K. J. et al. Rare and common genetic variation underlying the risk of hypertrophic cardiomyopathy in a national biobank. JAMA Cardiol. 7, 715\u2013722 (2022).","journal-title":"JAMA Cardiol."},{"key":"1096_CR9","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2209046","volume":"388","author":"CF Wright","year":"2023","unstructured":"Wright, C. F. et al. Genomic diagnosis of rare pediatric disease in the United Kingdom and Ireland. N. Engl. J. Med. 388, 1559\u20131571 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1096_CR10","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41591-023-02401-9","volume":"29","author":"S Lunke","year":"2023","unstructured":"Lunke, S. et al. Integrated multi-omics for rapid rare disease diagnosis on a national scale. Nat. Med. 29, 1681\u20131691 (2023).","journal-title":"Nat. Med."},{"key":"1096_CR11","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck, D. B. et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N. Engl. J. Med. 383, 2628\u20132638 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1096_CR12","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen, J. C., Boerwinkle, E., Mosley, T. H. Jr & Hobbs, H. H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354, 1264\u20131272 (2006).","journal-title":"N. Engl. J. Med."},{"key":"1096_CR13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41591-020-0893-5","volume":"26","author":"N Whiffin","year":"2020","unstructured":"Whiffin, N. et al. The effect of LRRK2 loss-of-function variants in humans. Nat. Med. 26, 869\u2013877 (2020).","journal-title":"Nat. Med."},{"key":"1096_CR14","doi-asserted-by":"crossref","first-page":"eabf8683","DOI":"10.1126\/science.abf8683","volume":"373","author":"P Akbari","year":"2021","unstructured":"Akbari, P. et al. Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity. Science 373, eabf8683 (2021).","journal-title":"Science"},{"key":"1096_CR15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856\u2013860 (2015).","journal-title":"Nat. Genet."},{"key":"1096_CR16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/annrheumdis-2019-216694","volume":"79","author":"E Myasoedova","year":"2020","unstructured":"Myasoedova, E., Davis, J., Matteson, E. L. & Crowson, C. S. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014. Ann. Rheum. Dis. 79, 440\u2013444 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1096_CR17","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/art.38097","volume":"65","author":"T Frisell","year":"2013","unstructured":"Frisell, T. et al. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor\/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age. Arthritis Rheum. 65, 2773\u20132782 (2013).","journal-title":"Arthritis Rheum."},{"key":"1096_CR18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057304","volume":"8","author":"AJ Svendsen","year":"2013","unstructured":"Svendsen, A. J. et al. On the origin of rheumatoid arthritis: the impact of environment and genes \u2014 a population based twin study. PLoS One 8, e57304 (2013).","journal-title":"PLoS One"},{"key":"1096_CR19","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1172\/JCI108382","volume":"57","author":"P Stastny","year":"1976","unstructured":"Stastny, P. Mixed lymphocyte cultures in rheumatoid arthritis. J. Clin. Invest. 57, 1148\u20131157 (1976).","journal-title":"J. Clin. Invest."},{"key":"1096_CR20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/138920207783591690","volume":"8","author":"SC Gough","year":"2007","unstructured":"Gough, S. C. & Simmonds, M. J. The HLA region and autoimmune disease: associations and mechanisms of action. Curr. Genomics 8, 453\u2013465 (2007).","journal-title":"Curr. Genomics"},{"key":"1096_CR21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41439-022-00226-5","volume":"9","author":"JK Kulski","year":"2022","unstructured":"Kulski, J. K., Suzuki, S. & Shiina, T. Human leukocyte antigen super-locus: nexus of genomic supergenes, SNPs, indels, transcripts, and haplotypes. Hum. Genome Var. 9, 49 (2022).","journal-title":"Hum. Genome Var."},{"key":"1096_CR22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen, P. K., Silver, J. & Winchester, R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205\u20131213 (1987).","journal-title":"Arthritis Rheum."},{"key":"1096_CR23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.1076","volume":"44","author":"S Raychaudhuri","year":"2012","unstructured":"Raychaudhuri, S. et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44, 291\u2013296 (2012).","journal-title":"Nat. Genet."},{"key":"1096_CR24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/422827","volume":"75","author":"AB Begovich","year":"2004","unstructured":"Begovich, A. B. et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75, 330\u2013337 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"1096_CR25","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.4049\/jimmunol.179.7.4704","volume":"179","author":"M Rieck","year":"2007","unstructured":"Rieck, M. et al. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J. Immunol. 179, 4704\u20134710 (2007).","journal-title":"J. Immunol."},{"key":"1096_CR26","unstructured":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007)."},{"key":"1096_CR27","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41588-022-01213-w","volume":"54","author":"K Ishigaki","year":"2022","unstructured":"Ishigaki, K. et al. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. Nat. Genet. 54, 1640\u20131651 (2022).","journal-title":"Nat. Genet."},{"key":"1096_CR28","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2013-205009","volume":"74","author":"JA Sparks","year":"2015","unstructured":"Sparks, J. A. et al. Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history. Ann. Rheum. Dis. 74, 1522\u20131529 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"1096_CR29","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/rheumatology\/kez638","volume":"59","author":"S Rostami","year":"2020","unstructured":"Rostami, S., Hoff, M., Brown, M. A., Hveem, K. & Videm, V. Comparison of methods to construct a genetic risk score for prediction of rheumatoid arthritis in the population-based Nord-Trondelag Health Study, Norway. Rheumatology 59, 1743\u20131751 (2020).","journal-title":"Rheumatology"},{"key":"1096_CR30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747\u2013753 (2009).","journal-title":"Nature"},{"key":"1096_CR31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ng.2232","volume":"44","author":"EA Stahl","year":"2012","unstructured":"Stahl, E. A. et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat. Genet. 44, 483\u2013489 (2012).","journal-title":"Nat. Genet."},{"key":"1096_CR32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2001248118","volume":"118","author":"F Rapaport","year":"2021","unstructured":"Rapaport, F. et al. Negative selection on human genes underlying inborn errors depends on disease outcome and both the mode and mechanism of inheritance. Proc. Natl Acad. Sci. USA 118, e2001248118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1096_CR33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2014.06.009","volume":"95","author":"S Lee","year":"2014","unstructured":"Lee, S., Abecasis, G. R., Boehnke, M. & Lin, X. Rare-variant association analysis: study designs and statistical tests. Am. J. Hum. Genet. 95, 5\u201323 (2014).","journal-title":"Am. J. Hum. Genet."},{"key":"1096_CR34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s10038-020-00845-2","volume":"66","author":"Y Momozawa","year":"2021","unstructured":"Momozawa, Y. & Mizukami, K. Unique roles of rare variants in the genetics of complex diseases in humans. J. Hum. Genet. 66, 11\u201323 (2021).","journal-title":"J. Hum. Genet."},{"key":"1096_CR35","volume":"10","author":"D Diogo","year":"2015","unstructured":"Diogo, D. et al. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. PLoS One 10, e0122271 (2015).","journal-title":"PLoS One"},{"key":"1096_CR36","unstructured":"National Human Genome Research Institute. Human Genomic Variation. https:\/\/www.genome.gov\/about-genomics\/educational-resources\/fact-sheets\/human-genomic-variation (2023)."},{"key":"1096_CR37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ajhg.2012.06.007","volume":"91","author":"S Lee","year":"2012","unstructured":"Lee, S. et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am. J. Hum. Genet. 91, 224\u2013237 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"1096_CR38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1809315","volume":"381","author":"EE Eichler","year":"2019","unstructured":"Eichler, E. E. Genetic variation, comparative genomics, and the diagnosis of disease. N. Engl. J. Med. 381, 64\u201374 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1096_CR39","unstructured":"National Library of Medicine. Overview of Structural Variation. https:\/\/www.ncbi.nlm.nih.gov\/dbvar\/content\/overview\/ (2022)."},{"key":"1096_CR40","doi-asserted-by":"crossref","unstructured":"International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299\u20131320 (2005).","DOI":"10.1038\/nature04226"},{"key":"1096_CR41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/humu.22813","volume":"36","author":"SH Lelieveld","year":"2015","unstructured":"Lelieveld, S. H., Spielmann, M., Mundlos, S., Veltman, J. A. & Gilissen, C. Comparison of exome and genome sequencing technologies for the complete capture of protein-coding regions. Hum. Mutat. 36, 815\u2013822 (2015).","journal-title":"Hum. Mutat."},{"key":"1096_CR42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajhg.2012.11.012","volume":"92","author":"D Diogo","year":"2013","unstructured":"Diogo, D. et al. Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of rheumatoid arthritis. Am. J. Hum. Genet. 92, 15\u201327 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"1096_CR43","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.humimm.2021.02.012","volume":"82","author":"T Hu","year":"2021","unstructured":"Hu, T., Chitnis, N., Monos, D. & Dinh, A. Next-generation sequencing technologies: an overview. Hum. Immunol. 82, 801\u2013811 (2021).","journal-title":"Hum. Immunol."},{"key":"1096_CR44","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41576-020-0236-x","volume":"21","author":"GA Logsdon","year":"2020","unstructured":"Logsdon, G. A., Vollger, M. R. & Eichler, E. E. Long-read human genome sequencing and its applications. Nat. Rev. Genet. 21, 597\u2013614 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"1096_CR45","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson, S. et al. Variant interpretation using population databases: lessons from gnomAD. Hum. Mutat. 43, 1012\u20131030 (2022).","journal-title":"Hum. Mutat."},{"key":"1096_CR46","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/art.39301","volume":"67","author":"KR Simpfendorfer","year":"2015","unstructured":"Simpfendorfer, K. R. et al. Autoimmune disease-associated haplotypes of BLK exhibit lowered thresholds for B cell activation and expansion of Ig class-switched B cells. Arthritis Rheumatol. 67, 2866\u20132876 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1096_CR47","doi-asserted-by":"crossref","first-page":"100168","DOI":"10.1016\/j.xgen.2022.100168","volume":"2","author":"KJ Karczewski","year":"2022","unstructured":"Karczewski, K. J. et al. Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes. Cell Genom. 2, 100168 (2022).","journal-title":"Cell Genom."},{"key":"1096_CR48","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/annrheumdis-2021-221754","volume":"81","author":"S Saevarsdottir","year":"2022","unstructured":"Saevarsdottir, S. et al. Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset. Ann. Rheum. Dis. 81, 1085\u20131095 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"1096_CR49","volume":"8","author":"D Gonz\u00e1lez-Serna","year":"2018","unstructured":"Gonz\u00e1lez-Serna, D. et al. Association of a rare variant of the TNFSF13B gene with susceptibility to rheumatoid arthritis and systemic lupus erythematosus. Sci. Rep. 8, 8195 (2018).","journal-title":"Sci. Rep."},{"key":"1096_CR50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/jhg.2013.2","volume":"58","author":"S Mitsunaga","year":"2013","unstructured":"Mitsunaga, S. et al. Exome sequencing identifies novel rheumatoid arthritis-susceptible variants in the BTNL2. J. Hum. Genet. 58, 210\u2013215 (2013).","journal-title":"J. Hum. Genet."},{"key":"1096_CR51","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/jhg.2015.50","volume":"60","author":"S Mitsunaga","year":"2015","unstructured":"Mitsunaga, S. et al. Aggregation of rare\/low-frequency variants of the mitochondria respiratory chain-related proteins in rheumatoid arthritis patients. J. Hum. Genet. 60, 449\u2013454 (2015).","journal-title":"J. Hum. Genet."},{"key":"1096_CR52","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s13075-014-0447-7","volume":"16","author":"SY Bang","year":"2014","unstructured":"Bang, S. Y. et al. Targeted exon sequencing fails to identify rare coding variants with large effect in rheumatoid arthritis. Arthritis Res. Ther. 16, 447 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"1096_CR53","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.2462","volume":"44","author":"S Eyre","year":"2012","unstructured":"Eyre, S. et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet. 44, 1336\u20131340 (2012).","journal-title":"Nat. Genet."},{"key":"1096_CR54","doi-asserted-by":"crossref","first-page":"603","DOI":"10.46497\/ArchRheumatol.2021.8127","volume":"36","author":"K Pang Leong","year":"2021","unstructured":"Pang Leong, K. et al. Missense variant in interleukin-6 signal transducer identified as susceptibility locus for rheumatoid arthritis in Chinese patients. Arch. Rheumatol. 36, 603\u2013610 (2021).","journal-title":"Arch. Rheumatol."},{"key":"1096_CR55","doi-asserted-by":"crossref","first-page":"819929","DOI":"10.3389\/fimmu.2022.819929","volume":"13","author":"N Pernaa","year":"2022","unstructured":"Pernaa, N. et al. Heterozygous premature termination in zinc-finger domain of Kr\u00fcppel-like factor 2 gene associates with dysregulated immunity. Front. Immunol. 13, 819929 (2022).","journal-title":"Front. Immunol."},{"key":"1096_CR56","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/annrheumdis-2019-215533","volume":"79","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome highlight T cell-initiated autoimmunity. Ann. Rheum. Dis. 79, 268\u2013275 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1096_CR57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213387","volume":"14","author":"M Veyssiere","year":"2019","unstructured":"Veyssiere, M. et al. A novel nonsense variant in SUPT20H gene associated with rheumatoid arthritis identified by whole exome sequencing of multiplex families. PLoS One 14, e0213387 (2019).","journal-title":"PLoS One"},{"key":"1096_CR58","volume":"9","author":"Y Okada","year":"2014","unstructured":"Okada, Y. et al. Integration of sequence data from a consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene. PLoS One 9, e87645 (2014).","journal-title":"PLoS One"},{"key":"1096_CR59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett, F. C. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315\u2013324 (1988).","journal-title":"Arthritis Rheum."},{"key":"1096_CR60","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569\u20132581 (2010).","journal-title":"Arthritis Rheum."},{"key":"1096_CR61","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/rheumatology\/keac068","volume":"61","author":"A Barbulescu","year":"2022","unstructured":"Barbulescu, A. et al. Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data. Rheumatology 61, 3952\u20133962 (2022).","journal-title":"Rheumatology"},{"key":"1096_CR62","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu, X., Li, J., Fu, M., Zhao, X. & Wang, W. The JAK\/STAT signaling pathway: from bench to clinic. Signal. Transduct. Target. Ther. 6, 402 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1096_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4331\/wjbc.v13.i1.1","volume":"13","author":"R Muromoto","year":"2022","unstructured":"Muromoto, R., Oritani, K. & Matsuda, T. Current understanding of the role of tyrosine kinase 2 signaling in immune responses. World J. Biol. Chem. 13, 1\u201314 (2022).","journal-title":"World J. Biol. Chem."},{"key":"1096_CR64","doi-asserted-by":"crossref","first-page":"734966","DOI":"10.3389\/fimmu.2021.734966","volume":"12","author":"S L\u00f3pez-L\u00f3pez","year":"2021","unstructured":"L\u00f3pez-L\u00f3pez, S. et al. NOTCH4 exhibits anti-inflammatory activity in activated macrophages by interfering with interferon-\u03b3 and TLR4 signaling. Front. Immunol. 12, 734966 (2021).","journal-title":"Front. Immunol."},{"key":"1096_CR65","doi-asserted-by":"crossref","first-page":"eabn2888","DOI":"10.1126\/sciimmunol.abn2888","volume":"7","author":"K Yang","year":"2022","unstructured":"Yang, K. et al. The mammalian SKIV2L RNA exosome is essential for early B cell development. Sci. Immunol. 7, eabn2888 (2022).","journal-title":"Sci. Immunol."},{"key":"1096_CR66","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140869","volume":"132","author":"Y Matsumoto","year":"2022","unstructured":"Matsumoto, Y. et al. Tankyrase represses autoinflammation through the attenuation of TLR2 signaling. J. Clin. Invest. 132, e140869 (2022).","journal-title":"J. Clin. Invest."},{"key":"1096_CR67","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/imm.12694","volume":"150","author":"A Lapenna","year":"2017","unstructured":"Lapenna, A., Omar, I. & Berger, M. A novel spontaneous mutation in the TAP2 gene unravels its role in macrophage survival. Immunology 150, 432\u2013443 (2017).","journal-title":"Immunology"},{"key":"1096_CR68","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10875-007-9118-7","volume":"27","author":"NP Hoff","year":"2007","unstructured":"Hoff, N. P., Degrandi, D., Hengge, U., Pfeffer, K. & Wurthner, J. U. Carboxypeptidase D: a novel TGF-\u03b2\u00a0target gene dysregulated in patients with lupus erythematosus. J. Clin. Immunol. 27, 568\u2013579 (2007).","journal-title":"J. Clin. Immunol."},{"key":"1096_CR69","first-page":"1835","volume":"12","author":"S Wang","year":"2019","unstructured":"Wang, S., Wang, S., Li, H., Zhu, L. & Wang, Y. Inhibition of the TGF-\u03b2\/Smads signaling pathway attenuates pulmonary fibrosis and induces anti-proliferative effect on synovial fibroblasts in rheumatoid arthritis. Int. J. Clin. Exp. Pathol. 12, 1835\u20131845 (2019).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"1096_CR70","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.20182010","volume":"216","author":"S Xing","year":"2019","unstructured":"Xing, S. et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J. Exp. Med. 216, 847\u2013866 (2019).","journal-title":"J. Exp. Med."},{"key":"1096_CR71","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/imcb.12484","volume":"99","author":"KR Wilson","year":"2021","unstructured":"Wilson, K. R., Villadangos, J. A. & Mintern, J. D. Dendritic cell Flt3 \u2014 regulation, roles and repercussions for immunotherapy. Immunol. Cell Biol. 99, 962\u2013971 (2021).","journal-title":"Immunol. Cell Biol."},{"key":"1096_CR72","doi-asserted-by":"crossref","first-page":"614781","DOI":"10.3389\/fimmu.2020.614781","volume":"11","author":"H Fan","year":"2020","unstructured":"Fan, H. et al. Plasma TNFSF13B and TNFSF14 function as inflammatory indicators of severe adenovirus pneumonia in pediatric patients. Front. Immunol. 11, 614781 (2020).","journal-title":"Front. Immunol."},{"key":"1096_CR73","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1093\/hmg\/dds220","volume":"21","author":"KR Simpfendorfer","year":"2012","unstructured":"Simpfendorfer, K. R. et al. The autoimmunity-associated BLK haplotype exhibits cis-regulatory effects on mRNA and protein expression that are prominently observed in B cells early in development. Hum. Mol. Genet. 21, 3918\u20133925 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"1096_CR74","volume":"3","author":"AP Morris","year":"2009","unstructured":"Morris, A. P., Zeggini, E. & Lindgren, C. M. Identification of novel putative rheumatoid arthritis susceptibility genes via analysis of rare variants. BMC Proc. 3, S131 (2009).","journal-title":"BMC Proc."},{"key":"1096_CR75","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00439-010-0889-1","volume":"128","author":"J Bowes","year":"2010","unstructured":"Bowes, J. et al. Rare variation at the TNFAIP3 locus and susceptibility to rheumatoid arthritis. Hum. Genet. 128, 627\u2013633 (2010).","journal-title":"Hum. Genet."},{"key":"1096_CR76","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ejhg.2015.95","volume":"24","author":"L Franke","year":"2016","unstructured":"Franke, L. et al. Association analysis of copy numbers of FC-\u03b3 receptor genes for rheumatoid arthritis and other immune-mediated phenotypes. Eur. J. Hum. Genet. 24, 263\u2013270 (2016).","journal-title":"Eur. J. Hum. Genet."},{"key":"1096_CR77","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41591-021-01672-4","volume":"28","author":"S Fatumo","year":"2022","unstructured":"Fatumo, S. et al. A roadmap to increase diversity in genomic studies. Nat. Med. 28, 243\u2013250 (2022).","journal-title":"Nat. Med."},{"key":"1096_CR78","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584\u2013591 (2019).","journal-title":"Nat. Genet."},{"key":"1096_CR79","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-021-07618-x","volume":"22","author":"H Carress","year":"2021","unstructured":"Carress, H., Lawson, D. J. & Elhaik, E. Population genetic considerations for using biobanks as international resources in the pandemic era and beyond. BMC Genomics 22, 351 (2021).","journal-title":"BMC Genomics"},{"key":"1096_CR80","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2019.08.051","volume":"179","author":"RE Peterson","year":"2019","unstructured":"Peterson, R. E. et al. Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations. Cell 179, 589\u2013603 (2019).","journal-title":"Cell"},{"key":"1096_CR81","volume":"6","author":"YR Li","year":"2014","unstructured":"Li, Y. R. & Keating, B. J. Trans-ethnic genome-wide association studies: advantages and challenges of mapping in diverse populations. Genome Med. 6, 91 (2014).","journal-title":"Genome Med."},{"key":"1096_CR82","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41588-020-00766-y","volume":"53","author":"EG Atkinson","year":"2021","unstructured":"Atkinson, E. G. et al. Tractor uses local ancestry to enable the inclusion of admixed individuals in GWAS and to boost power. Nat. Genet. 53, 195\u2013204 (2021).","journal-title":"Nat. Genet."},{"key":"1096_CR83","unstructured":"Johnson, J. L. Genetic Association Study Power Calculator. University of Michigan http:\/\/csg.sph.umich.edu\/abecasis\/cats\/gas_power_calculator\/index.html (2017)."},{"key":"1096_CR84","doi-asserted-by":"crossref","first-page":"K41","DOI":"10.1016\/j.vaccine.2013.03.075","volume":"31","author":"CP Chung","year":"2013","unstructured":"Chung, C. P., Rohan, P., Krishnaswami, S. & McPheeters, M. L. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data. Vaccine 31, K41\u2013K61 (2013).","journal-title":"Vaccine"},{"key":"1096_CR85","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog, L. et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 54, 38\u201346 (2006).","journal-title":"Arthritis Rheum."},{"key":"1096_CR86","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/gepi.20398","volume":"33","author":"R Xiao","year":"2009","unstructured":"Xiao, R. & Boehnke, M. Quantifying and correcting for the winner\u2019s curse in genetic association studies. Genet. Epidemiol. 33, 453\u2013462 (2009).","journal-title":"Genet. Epidemiol."},{"key":"1096_CR87","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2217\/14622416.10.2.191","volume":"10","author":"E Zeggini","year":"2009","unstructured":"Zeggini, E. & Ioannidis, J. P. Meta-analysis in genome-wide association studies. Pharmacogenomics 10, 191\u2013201 (2009).","journal-title":"Pharmacogenomics"},{"key":"1096_CR88","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12170","volume":"498","author":"KA Hunt","year":"2013","unstructured":"Hunt, K. A. et al. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 498, 232\u2013235 (2013).","journal-title":"Nature"},{"key":"1096_CR89","volume":"10","author":"SH Jiang","year":"2019","unstructured":"Jiang, S. H. et al. Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus. Nat. Commun. 10, 2201 (2019).","journal-title":"Nat. Commun."},{"key":"1096_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/0471250953.bi0119s32","author":"M Bhagwat","year":"2010","unstructured":"Bhagwat, M. Searching NCBI\u2019s dbSNP database. Curr. Protoc. Bioinformatics\u00a0https:\/\/doi.org\/10.1002\/0471250953.bi0119s32 (2010).","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"1096_CR91","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/bioinformatics\/btu137","volume":"30","author":"JP Kocher","year":"2014","unstructured":"Kocher, J. P. et al. The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation. Bioinformatics 30, 1920\u20131922 (2014).","journal-title":"Bioinformatics"},{"key":"1096_CR92","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-015-0195-6","volume":"7","author":"M M\u00fcnz","year":"2015","unstructured":"M\u00fcnz, M. et al. CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting. Genome Med. 7, 76 (2015).","journal-title":"Genome Med."},{"key":"1096_CR93","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/nprot.2015.105","volume":"10","author":"H Yang","year":"2015","unstructured":"Yang, H. & Wang, K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat. Protoc. 10, 1556\u20131566 (2015).","journal-title":"Nat. Protoc."},{"key":"1096_CR94","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis, N. M. et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877\u2013885 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"1096_CR95","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886\u2013d894 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1096_CR96","doi-asserted-by":"crossref","DOI":"10.1186\/s40246-023-00451-1","volume":"17","author":"JM de Sainte Agathe","year":"2023","unstructured":"de Sainte Agathe, J. M. et al. SpliceAI-visual: a free online tool to improve SpliceAI splicing variant interpretation. Hum. Genomics 17, 7 (2023).","journal-title":"Hum. Genomics"},{"key":"1096_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/0471142905.hg0720s76","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. https:\/\/doi.org\/10.1002\/0471142905.hg0720s76 (2013).","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"1096_CR98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nprot.2015.123","volume":"11","author":"R Vaser","year":"2016","unstructured":"Vaser, R., Adusumalli, S., Leng, S. N., Sikic, M. & Ng, P. C. SIFT missense predictions for genomes. Nat. Protoc. 11, 1\u20139 (2016).","journal-title":"Nat. Protoc."},{"key":"1096_CR99","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41436-020-0766-9","volume":"22","author":"HA Wai","year":"2020","unstructured":"Wai, H. A. et al. Blood RNA analysis can increase clinical diagnostic rate and resolve variants of uncertain significance. Genet. Med. 22, 1005\u20131014 (2020).","journal-title":"Genet. Med."},{"key":"1096_CR100","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/humu.23892","volume":"40","author":"L Wiel","year":"2019","unstructured":"Wiel, L. et al. MetaDome: pathogenicity analysis of genetic variants through aggregation of homologous human protein domains. Hum. Mutat. 40, 1030\u20131038 (2019).","journal-title":"Hum. Mutat."},{"key":"1096_CR101","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng.3466","volume":"48","author":"X Zhou","year":"2016","unstructured":"Zhou, X. et al. Exploring genomic alteration in pediatric cancer using ProteinPaint. Nat. Genet. 48, 4\u20136 (2016).","journal-title":"Nat. Genet."},{"key":"1096_CR102","doi-asserted-by":"crossref","first-page":"12412","DOI":"10.1073\/pnas.0906217106","volume":"106","author":"S Chattopadhyay","year":"2009","unstructured":"Chattopadhyay, S. et al. High frequency of hotspot mutations in core genes of Escherichia coli due to short-term positive selection. Proc. Natl Acad. Sci. USA 106, 12412\u201312417 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1096_CR103","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41690-z","volume":"14","author":"P Ying","year":"2023","unstructured":"Ying, P. et al. Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk. Nat. Commun. 14, 5958 (2023).","journal-title":"Nat. Commun."},{"key":"1096_CR104","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","volume":"550","author":"A Battle","year":"2017","unstructured":"Battle, A., Brown, C. D., Engelhardt, B. E. & Montgomery, S. B. Genetic effects on gene expression across human tissues. Nature 550, 204\u2013213 (2017).","journal-title":"Nature"},{"key":"1096_CR105","unstructured":"GTEx Portal. Bulk tissue gene expression for PTPN22 (ENSG00000134242.15). https:\/\/gtexportal.org\/home\/gene\/PTPN22 (2021)."},{"key":"1096_CR106","doi-asserted-by":"crossref","first-page":"eabf2846","DOI":"10.1126\/sciimmunol.abf2846","volume":"7","author":"DP Simmons","year":"2022","unstructured":"Simmons, D. P. et al. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. Sci. Immunol. 7, eabf2846 (2022).","journal-title":"Sci. Immunol."},{"key":"1096_CR107","unstructured":"National Institutes of Health. Accelerating Medicines Partnership (AMP). https:\/\/www.nih.gov\/research-training\/accelerating-medicines-partnership-amp#:~:text=Launched%20in%202014%2C%20the%20Accelerating,to%20transform%20the%20current%20model (2022)."},{"key":"1096_CR108","unstructured":"The Arthritis and Autoimmune and Related Diseases Portal. Rheumatoid Arthritis Phase II (RA_PhaseII). ARK https:\/\/arkportal.synapse.org\/Explore\/Projects\/DetailsPage?Project=RA_PhaseII (2024)."},{"key":"1096_CR109","doi-asserted-by":"crossref","first-page":"151937","DOI":"10.1016\/j.semarthrit.2021.11.008","volume":"52","author":"VL Kronzer","year":"2022","unstructured":"Kronzer, V. L. et al. Timing of sinusitis and other respiratory tract diseases and risk of rheumatoid arthritis. Semin. Arthritis Rheum. 52, 151937 (2022).","journal-title":"Semin. Arthritis Rheum."},{"key":"1096_CR110","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/art.40858","volume":"71","author":"VL Kronzer","year":"2019","unstructured":"Kronzer, V. L., Crowson, C. S., Sparks, J. A., Vassallo, R. & Davis, J. M. III Investigating asthma, allergic disease, passive smoke exposure, and risk of rheumatoid arthritis. Arthritis Rheumatol. 71, 1217\u20131224 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1096_CR111","unstructured":"National Human Genome Research Institute. The Cost of Sequencing a Human Genome. https:\/\/www.genome.gov\/about-genomics\/fact-sheets\/Sequencing-Human-Genome-cost [online] (2021)."},{"key":"1096_CR112","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","volume":"582","author":"K Wei","year":"2020","unstructured":"Wei, K. et al. Notch signalling drives synovial fibroblast identity and arthritis pathology. Nature 582, 259\u2013264 (2020).","journal-title":"Nature"},{"key":"1096_CR113","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13075-021-02419-9","volume":"23","author":"C Wu","year":"2021","unstructured":"Wu, C. et al. Transcriptome-wide association study identifies susceptibility genes for rheumatoid arthritis. Arthritis Res. Ther. 23, 38 (2021).","journal-title":"Arthritis Res. Ther."},{"key":"1096_CR114","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/art.40917","volume":"71","author":"M Asquith","year":"2019","unstructured":"Asquith, M. et al. HLA alleles associated with risk of ankylosing spondylitis and rheumatoid arthritis influence the gut microbiome. Arthritis Rheumatol. 71, 1642\u20131650 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1096_CR115","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/annrheumdis-2014-206047","volume":"74","author":"JA van Nies","year":"2015","unstructured":"van Nies, J. A., Tsonaka, R., Gaujoux-Viala, C., Fautrel, B. & van der Helm-van Mil, A. H. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts. Ann. Rheum. Dis. 74, 806\u2013812 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"1096_CR116","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","volume":"13","author":"D Cook","year":"2014","unstructured":"Cook, D. et al. Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: a five-dimensional framework. Nat. Rev. Drug. Discov. 13, 419\u2013431 (2014).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"1096_CR117","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/2047487320940102","volume":"28","author":"KC Koskinas","year":"2021","unstructured":"Koskinas, K. C. et al. Eligibility for PCSK9 inhibitors based on the 2019 ESC\/EAS and 2018 ACC\/AHA guidelines. Eur. J. Prev. Cardiol. 28, 59\u201365 (2021).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"1096_CR118","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa1109071","volume":"367","author":"R Fleischmann","year":"2012","unstructured":"Fleischmann, R. et al. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. N. Engl. J. Med. 367, 495\u2013507 (2012).","journal-title":"N. Engl. J. Med."},{"key":"1096_CR119","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23361-z","volume":"12","author":"SA Hasni","year":"2021","unstructured":"Hasni, S. A. et al. Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus. Nat. Commun. 12, 3391 (2021).","journal-title":"Nat. Commun."},{"key":"1096_CR120","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","volume":"376","author":"WJ Sandborn","year":"2017","unstructured":"Sandborn, W. J. et al. Tofacitinib as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 376, 1723\u20131736 (2017).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01096-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01096-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01096-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T13:06:34Z","timestamp":1714136794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01096-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":120,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1038\/s41584-024-01096-7","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"assertion":[{"value":"20 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.A.S. reports consulting fees from AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Inova Diagnostics, Janssen, Optum and Pfizer. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}